Zobrazeno 1 - 10
of 3 139
pro vyhledávání: '"M McLaughlin"'
Autor:
MJ Melake, HG Smith, D Mansfield, E Davies, MT Dillon, AC Wilkins, EC Patin, M Pedersen, R Buus, AA Melcher, K Thway, AB Miah, SH Zaidi, AJ Hayes, TR Fenton, KJ Harrington, M McLaughlin
Publikováno v:
OncoImmunology, Vol 11, Iss 1 (2022)
Systemic relapse after radiotherapy and surgery is the major cause of disease-related mortality in sarcoma patients. Combining radiotherapy and immunotherapy is under investigation as a means to improve response rates. However, the immune contexture
Externí odkaz:
https://doaj.org/article/81afcd7101924da99decc87c750acf06
Autor:
Aisling R. Caffrey, Haley J. Appaneal, Vrishali V. Lopes, Laura Puzniak, Evan J. Zasowski, Luis Jodar, Kerry L. LaPlante, John M. McLaughlin
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-10 (2024)
Abstract Data evaluating effectiveness of XBB.1.5-adapted vaccines against JN.1-related endpoints are scarce. This nationwide test-negative case-control study within the US Veterans Affairs Healthcare System aims to estimate vaccine effectiveness (VE
Externí odkaz:
https://doaj.org/article/605d13443f1c4c3c87c6d49b6f0d0dac
Publikováno v:
Infectious Diseases and Therapy, Vol 13, Iss 10, Pp 2203-2206 (2024)
Externí odkaz:
https://doaj.org/article/5e8f335c5f2b41ef9d40e854c71006e4
Autor:
Christopher J. Barnes, Maria Sophie Bünner, M. Rosario Ramírez-Flores, Ida Broman Nielsen, Jazmin Ramos-Madrigal, Daria Zharikova, Chloee M. McLaughlin, M. Thomas Gilbert, Ruairidh J.H. Sawers
Publikováno v:
Environmental Microbiome, Vol 19, Iss 1, Pp 1-14 (2024)
Summary Background The composition of the root microbiome affects the host’s growth, with variation in the host genome associated with microbiome variation. However, it is not known whether this intra-specific variation of root microbiomes is a con
Externí odkaz:
https://doaj.org/article/ddd962726e0a41e887fab10e5f00c52f
Autor:
Abby E. Rudolph, Farid L. Khan, Tanya G. Singh, Srinivas Rao Valluri, Laura A. Puzniak, John M. McLaughlin
Publikováno v:
Infectious Diseases and Therapy, Vol 13, Iss 9, Pp 2035-2052 (2024)
Abstract Introduction Although real-world studies demonstrate that those prescribed nirmatrelvir/ritonavir (and particularly within 5 days of symptom onset) are less likely to experience severe COVID-19 outcomes, prior studies show that only a small
Externí odkaz:
https://doaj.org/article/e054eaf1567e4fc8aa96a7d8270415d7
Autor:
Kate Penrose, Avantika Srivastava, Yanhan Shen, McKaylee M. Robertson, Sarah G. Kulkarni, Kristen E. Allen, Thomas M. Porter, Laura Puzniak, John M. McLaughlin, Denis Nash
Publikováno v:
Infectious Diseases and Therapy, Vol 13, Iss 8, Pp 1743-1757 (2024)
Abstract Introduction Oral antiviral medications are important tools for preventing severe COVID-19 outcomes. However, their uptake remains low for reasons that are not entirely understood. Our study aimed to assess the association between perceived
Externí odkaz:
https://doaj.org/article/339749dcc67f4dd9ba7c365dd21e7ae3
Autor:
Robyn von Maltzahn, Marlyn J. Mayo, Helen T. Smith, April Thompson, Sugato Das, Andrea Ribeiro de Souza, Edoardo Lisi, Cynthia Levy, Megan M. McLaughlin, David Jones
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 8, Iss 1, Pp 1-10 (2024)
Abstract Background Cholestatic pruritus and fatigue are debilitating conditions associated with primary biliary cholangitis (PBC) and can significantly impact patients’ quality of life. Pruritus in PBC often worsens at night and patients frequentl
Externí odkaz:
https://doaj.org/article/4d1af5d6eaee470a8aa825e7746d9486
Autor:
Jennifer L. Nguyen, Marianna Mitratza, Hannah R. Volkman, Leonie de Munter, Thao Mai Phuong Tran, Catia Marques, Mustapha Mustapha, Srinivas Valluri, Jingyan Yang, Andrés Antón, Irma Casas, Eduardo Conde-Sousa, Laura Drikite, Beate Grüner, Giancarlo Icardi, Gerrit Luit ten Kate, Charlotte Martin, Ainara Mira-Iglesias, Alejandro Orrico-Sánchez, Susana Otero-Romero, Gernot Rohde, Luis Jodar, John M. McLaughlin, Kaatje Bollaerts
Publikováno v:
EClinicalMedicine, Vol 79, Iss , Pp 102995- (2025)
Summary: Background: Prior studies have reported lower effectiveness of XBB.1.5-adapted vaccines against hospitalization related to the Omicron JN.1 variant than the XBB variant. This study evaluated the effectiveness and durability of the BNT162b2 X
Externí odkaz:
https://doaj.org/article/6a4716f5380547dc8a0d0874277b7715
Autor:
Megan M. McLaughlin, Alexis L. Beatty
Publikováno v:
American Journal of Preventive Cardiology, Vol 19, Iss , Pp 100703- (2024)
Hypertension is an important modifiable risk factor for cardiovascular disease and affects nearly one-third of women in the U.S. Prior research has demonstrated declining rates of blood pressure (BP) control nationally among women, and there are sign
Externí odkaz:
https://doaj.org/article/19f1f9fb5f38476dbc00b0781f061e59
Autor:
Deborah E. Malden, John M. McLaughlin, Vennis Hong, Joseph Lewnard, Bradley K. Ackerson, Laura Puzniak, Jeniffer S. Kim, Harpreet Takhar, Timothy B. Frankland, Jeff M. Slezak, Sara Y. Tartof
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract A clear understanding of real-world uptake of nirmatrelvir–ritonavir for treatment of SARS-CoV-2 can inform treatment allocation strategies and improve interpretation of effectiveness studies. We used data from a large US healthcare system
Externí odkaz:
https://doaj.org/article/d3fe580778384714bf7e778dfa12f3e1